PPT-A NEW ERA in IPF:

Trials and Treatments Craig Thurm MD Director Pulmonary Medicine Director Pulmonary Fellowship Medical Director Respiratory Care Jamaica Hospital Medical Center Disclosure of Relevant . Case Presentation: Familial IPF. 56-year-old Hispanic female with a family history of aortic aneurysm underwent a routine chest CT to assess her aorta. No respiratory symptoms. Medical history . h/o SVT. (ILD). Mike McFarlane (CT1). 12/5/12. SLIME. What we’ll cover. Definition. Different types of ILD. Pathophysiology. Presentation. Investigations. Management. Prognosis. Clinical Scenario. Summary. What we won’t.... Comorbidities and Complications. FACULTY. Title. Affiliation. Learning Objectives. Identify approaches to IPF management that are covered in current . guidelines. , taking into account the strength of relevant . Diagnosis and Monitoring. Kevin R. Flaherty, MD, . MS.  . Associate Professor. Pulmonary and Critical Care Medicine. University of Michigan Health System. Ann Arbor, Michigan. Faculty Disclosure. . – . The need for early recognition and referral. PRC-2128. It can be difficult to separate idiopathic pulmonary fibrosis (IPF) from other conditions. IPF is a rare but fatal lung disease, with a lower survival rate than many common malignancies. Educational Activity Learning Objective. Upon completion of this course, the participants should be able to:. Explain the considerations associated with clinical evaluation, imaging, and surgical . biopsy . Discussing Prognosis &. Goals of Care. Sonye K. . Danoff. , MD, . PhD. PULMONARY FIBROSIS. : WHAT AND . WHY. November 13, 2015. No conflict of interest relevant to this presentation. Objective of this talk. IMRE NOTH, MD. CLINICAL CARE: NEW AND EVOLVING TREATMENT STRATEGIES . NOVEMBER 14, 2015. What is “Precision” Medicine?. Precision medicine. is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person.. Diagnosing Idiopathic Pulmonary Fibrosis. FACULTY. Title. Affiliation. Learning Objectives. Explain the considerations associated with . clinical evaluation, imaging, and . biopsy. , in terms of differentially diagnosing . 56-year-old Hispanic female with a family history of aortic aneurysm underwent a routine chest CT to assess her aorta. No respiratory symptoms. Medical history . h/o SVT. Type 2 diabetes mellitus. Hypertension. The . Next Steps in Individualizing Treatment. Learning Objectives. As a result of attending this activity, participants should be able to. :. Select . appropriate therapies that reflect current evidence and/ or widely accepted guidelines that are individualized to patients . (. P. ulmonary Fibrosis . I. dentification: . L. essons for . O. ptimizing . T. reatment) is a national education initiative driven by The France Foundation, an ACCME-accredited . provider. Education focuses . Università degli Studi di Padova. Terapia della fibrosi polmonare idiopatica. IPF is . an unpredictable and ultimately fatal age-related interstitial lung disease of unknown cause with a median survival of approximately 3-5 years after diagnosis. Department. of . Diseases. of the . Thorax. , Ospedale GB . Morgagni. , Forlì (I). Department. of . Respiratory. . Diseases. & . Allergy. , . Aarhus. . University. Hospital, . Aarhus. (DK).